Circurna
PrivateLast Round
Seed
Nov 1, 2025
Total Funding Raised
$4.25M
Company Overview
Circurna (formerly Emervax) is a biotechnology company developing next-generation vaccines and therapeutics using a proprietary circular RNA platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
circular RNAciRNARNA therapeuticsdrug deliverythermostable nanoparticlesmicroneedle patchtransdermal deliverynext-gen mRNAbiotech platformAI drug discoverycold-chain freeRNA medicinebiotech licensingLNP formulationpre-clinical biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circurna Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Circurna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Series A | Aug 25, 2025 | ||||
| Grant | Jan 23, 2024 | ||||
| Grant | Oct 24, 2023 |
Circurna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| DHSC | Grant |
| Innovate UK Contracts for Innovation | Grant |
Circurna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Circurna's valuation, stock price, and market status.